» Articles » PMID: 31291253

Cardiovascular Effects of Intravenous Colforsin in Normal and Acute Respiratory Acidosis Canine Models: A Dose-response Study

Overview
Journal PLoS One
Date 2019 Jul 11
PMID 31291253
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In acidosis, catecholamines are attenuated, and higher doses are often required to improve cardiovascular function. Colforsin activates adenylate cyclase in cardiomyocytes without beta-adrenoceptor. Here, six beagles were administered colforsin or dobutamine four times during eucapnia (partial pressure of arterial carbon dioxide 35-40 mm Hg; normal) and hypercapnia (ibid 90-110 mm Hg; acidosis) conditions. The latter was induced by CO2 inhalation. Anesthesia was induced with propofol and maintained with isoflurane. Cardiovascular function was measured by thermodilution and a Swan-Ganz catheter at baseline and 60 min after 0.3 μg/kg/min (low), 0.6 μg/kg/min (middle), and 1.2 μg/kg/min (high) colforsin administration. The median pH was 7.38 [range 7.33-7.42] and 7.01 [range 6.96-7.08] at baseline in the Normal and Acidosis conditions, respectively. Endogenous adrenaline and noradrenaline levels at baseline were significantly (P < 0.05) higher in the Acidosis than in the Normal condition. Colforsin induced cardiovascular effects similar to those caused by dobutamine. Colforsin increased cardiac output in the Normal condition (baseline: 3.9 ± 0.2 L/kg/m2 [mean ± standard error], low: 5.2 ± 0.4 L/kg/min2, middle: 7.0 ± 0.4 L/kg/m2, high: 9.4 ± 0.2 L/kg/m2; P < 0.001) and Acidosis condition (baseline: 6.1 ± 0.3 L/kg/m2, low: 6.2 ± 0.2 L/kg/m2, middle: 7.2 ± 0.2 L/kg/m2, high: 8.3 ± 0.2 L/kg/m2; P < 0.001). Colforsin significantly increased heart rate and decreased systemic vascular resistance compared to values at baseline. Both drugs increased pulmonary artery pressure, but colforsin (high: 13.3 ± 0.6 mmHg in Normal and 20.1 ± 0.2 mmHg in Acidosis) may have lower clinical impact on the pulmonary artery than dobutamine (high: 19.7 ± 0.6 in Normal and 26.7 ± 0.5 in Acidosis). Interaction between both drugs and experimental conditions was observed in terms of cardiovascular function, which were similarly attenuated with colforsin and dobutamine under acute respiratory acidosis.

Citing Articles

Cardiorespiratory effects of intramuscular alfaxalone combined with low-dose medetomidine and butorphanol in dogs anesthetized with sevoflurane.

Kato K, Itami T, Oyama N, Yamashita K Open Vet J. 2024; 14(5):1251-1258.

PMID: 38938419 PMC: 11199746. DOI: 10.5455/OVJ.2024.v14.i5.20.


Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles.

Maghsoudi S, Shuaib R, Van Bastelaere B, Dakshinamurti S Front Pharmacol. 2024; 15:1370506.

PMID: 38633617 PMC: 11021717. DOI: 10.3389/fphar.2024.1370506.


Use of a gum elastic bougie in a cat with severe upper airway stenosis.

Kato K, Itami T, Torisu S, Sakai T, Yamashita K Open Vet J. 2023; 13(1):114-118.

PMID: 36777444 PMC: 9897496. DOI: 10.5455/OVJ.2023.v13.i1.12.


Evaluation of Renal Blood Flow in Dogs during Short-Term Human-Dose Epoprostenol Administration Using Pulsed Doppler and Contrast-Enhanced Ultrasonography.

Hanazono K, Itami T, Hayasaka I, Miyoshi K, Hori A, Kato K Animals (Basel). 2022; 12(9).

PMID: 35565601 PMC: 9103000. DOI: 10.3390/ani12091175.

References
1.
Wattwil L, Olsson J . Circulatory effects of isoflurane during acute hypercapnia. Anesth Analg. 1987; 66(12):1234-9. View

2.
Shebuski R, SMITH Jr J, Ruffolo Jr R . Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog. Pharmacology. 1988; 36(1):35-43. DOI: 10.1159/000138344. View

3.
Schotola H, Toischer K, Popov A, Renner A, Schmitto J, Gummert J . Mild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardium. Crit Care. 2012; 16(4):R153. PMC: 3580742. DOI: 10.1186/cc11468. View

4.
Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J . Glucose metabolism and catecholamines. Crit Care Med. 2007; 35(9 Suppl):S508-18. DOI: 10.1097/01.CCM.0000278047.06965.20. View

5.
Simonneau G, Robbins I, Beghetti M, Channick R, Delcroix M, Denton C . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009; 54(1 Suppl):S43-S54. DOI: 10.1016/j.jacc.2009.04.012. View